All sponsors

Guangdong Raynovent Biotech Co., Ltd

Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-18
ACTIVE TRIALS5
PHASE 3 / 2-33
RECRUITING2
READOUTS ≤12 MONTHS2
READOUT SLIPPED >6 MO20%

Delay Index: of 5 active trials registered more than a year ago, 1 have moved their primary completion (readout) date by more than 6 months since first registration (median +0.0 months). See all sponsors →

Open Guangdong Raynovent Biotech Co., Ltd on the live radar map →
TRIALPHASESTATUSCONDITIONNPRIMARY COMPLETION
RAY1225
NCT06254261
P2RecruitingObesity2702025-12-20 (+12 mo)
RAY1225
NCT06893016
P3RecruitingObesity6402026-06-15
ZSP1601
NCT05692492
P2Active, not recruitingNonalcoholic Steatohepatitis (NASH)1802026-06-16
RAY1225
NCT07139535
P3Not yet recruitingT2DM3502026-12-01
RAY1225
NCT07139548
P3Not yet recruitingT2DM6002026-12-01